Police in Thrissur, Kerala, arrested a man after a drug raid. He attempted to hide ganja inside a pressure cooker filled with rice. The unu...

An accidental discovery in a rubber factory in the 1930s revealed that workers exposed to tetraethylthiuram disulfide experienced severe re...

There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...

Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...

Here’s a thing investors in equity need to keep in mind. A large part of the upmove one might see in the next one or two trading sessions w...

China and the United States have agreed to reduce tariffs on certain goods. This move aims to boost trade between the two nations, particul...

A scientific breakthrough offers a new way to produce vitamin B12. Researchers are using managed light on Spirulina, a blue-green algae. Th...

As global markets prioritise quality and regulatory trust, India’s pharma sector is recalibrating beyond its traditional cost advantage.

Excise officials in Hyderabad arrested a former software engineer for cultivating cannabis plants on his terrace. Investigators linked the ...

The violence erupted following the seizure of a large quantity of drugs from a suspected drug peddler at the Imphal airport.

The United States has introduced tariffs on branded drug imports. However, many exemptions will limit their effect. Companies investing in ...

The Supreme Court has denied former IPS officer Sanjiv Bhatt's request to halt his 20-year prison sentence. This sentence stems from a 1996...

Stanford scientists have used a common laboratory plant to produce a widely used cancer fighting drug - previously only available from an e...

India’s drug regulator has ordered Ranbaxy to furnish a comprehensive explanation for the violation of manufacturing practices at its Toans...

Indian regulators' disconnect with global counterparts prevents access to inspection notification or to their findings.

DCGI is readying a plan to check if domestic bulk drug facilities that export to the European Union comply with WHO-prescribed norms.

The US Food and Drug Administration (FDA) has found nine deviations in Indian drug maker Cipla’s manufacturing process during a recent insp...